KKR made a minority investment in Oyster Point Pharma.

Synopsis

Private equity firm KKR & Co, through its investment platform Falcon Vision, made a minority investment in Oyster Point Pharma, a clinical-stage pharmaceutical company that develops therapies to treat Dry Eye Disease. Financial terms were not disclosed.

Principals

target

Oyster Point Pharma

bidder

Kkr & Co

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

bidder

5445

Deals

£ 3,505.44 B

Total Value